AN. VET. (MURCIA) 26: 5-21 (2010). PATHOGENICITY OF HISTOPHILUS SOMNI. PÉREZ, D. S., ET AL. 5

HISTOPHILUS SOMNI: PATHOGENICITY IN CATTLE. AN UPDATE

Histophilus somni: actualización de la patogenicidad en vacuno

Pérez, D. S.1; Pérez, F. A.2; Bretschneider, G.*3

1 Facultad de Veterinaria, UNCPBA, Campus Universitario B7000 – Tandil, Buenos Aires, Argen- tina. 2Newton 985 - Bahía Blanca (8000) - Pcia de Buenos Aires, Argentina. 3 Instituto Nacional de Tecnología Agropecuaria (INTA), Estación Experimental Agropecuaria Rafaela. Área de Inves- tigación en Producción. Rafaela Ruta 34 - Km 227, CC 22, Rafaela (2300), Santa Fe, Argentina.

* Autor para correspondencia: Gustavo Bretschneider. Email: [email protected]

ABSTRACT

Histophilus somni (H. somni) is a Gram-negative bacterium currently classified as a member of the Hae- mophilus-Actinobacillus-Pasteurella group. Clinical syndromes associated with H. somni infection involve thromboembolic meningoencephalitis, and disease of the reproductive tract in cattle. Animals can be carriers of non-pathogenic variants of the organism, mainly in the genital mucosa. The causes of these dif- ferences in between strains are not defined. Several determinants of virulence of the pathogen are proposed. However, many of these factors cannot be clearly related to clinical disease. H. somni avoids killing by phagocytic cells. Thus, it is able to evade the immune response by intracellular survival in the infected host.

The bovine adaptive immune response against H. somni is not completely characterized. IgG2 antibodies are thought to be protective. However, the major antigen determinants of the bacterium are still unknown. Studies with H. somni bacterins have inconsistent results, especially because the factors involved in pathogenesis and immune response remain unclear. Key words: Histophilus somni, cattle, clinical syndromes, virulence factors, carriers, diagnosis, vaccines.

RESUMEN

Histophilus somni (H. somni) es una Gram negativa actualmente clasificada como un miembro del grupo Haemophilus-Actinobacillus-Pasteurella (HAP). Los síndromes clínicos en el ganado bovino aso- ciados con la infección por H. somni incluyen meningoencefalitis tromboembólica, neumonía y enfermedad del tracto reproductivo. Los animales pueden ser portadores de variantes no patogénicas del microorganismo, principalmente en la mucosa genital. Las causas de las diferencias en la virulencia entre cepas no están defini- 6 AN. VET. (MURCIA) 26: 5-21 (2010). PATHOGENICITY OF HISTOPHILUS SOMNI. PÉREZ, D. S., ET AL. das. Se propusieron varios determinantes de la virulencia del patógeno. Sin embargo, muchos de estos factores no pueden relacionarse claramente con la enfermedad clínica. H. somni elude la destrucción por parte de las células fagocíticas. De este modo, es capaz de evadir la respuesta inmunitaria a través de la superviviencia en forma intracelular en el huésped infectado. La respuesta inmune adaptativa del bovino contra H. somni no está caracterizada completamente. Se estima que los anticuerpos IgG2 son protectores. Sin embargo, los principales determinantes antigénicos de la bacteria se desconocen. Los estudios con las bacterinas de H. somni han tenido resultados inconsistentes, especialmente debido a que los factores involucrados en la patogénesis y en la res- puesta inmunitaria permanecen sin esclarecer. Palabras claves: Histophilus somni, vacuno, síndromes clínicos, factores de virulencia, portadores, diag- nóstico, vacunas.

INTRODUCTION as well as the current knowledge on the carrier state, virulence determinants and host immune Histophilus somni (H. somni; ex-Haemo- response are described. Considerations on the philus somnus) is a Gram-negative bacterium of the disease, diagnosis and va- responsible for a variety of clinical syndromes ccine development are also presented. in cattle. These syndromes are particularly common in feedlot and dairy calves, although BIOLOGICAL PROPERTIES OF H. SOMNI they can also be observed in grazing cattle (Gri- AND TAXONOMIC CONSIDERATIONS ner et al. 1956; Crandell et al. 1977; Smith and Biberstein, 1977; Bastida-Corcuera et al. H. somni is a small, Gram-negative, non- 1999). Thromboembolic meningoencephalitis spore forming, pleomorphic bacilli (Kennedy et (TEME), pneumonia and pathological disor- al. 1960; Rosendal and Boyd 1986). It does not ders of the reproductive tract are the most fre- have a polysaccharide capsule and it does not quently observed clinical manifestations (Gri- express pili or flagella (Firehammer 1959; Ken- ner et al. 1956; Firehammer 1959; Kennedy nedy et al. 1960). Identification of H. somni by et al. 1960; Chladek 1975; Smith and Bibers- the routinely used biochemical tests is difficult tein 1977; Humphrey et al. 1982; Miller et al. due to its poor growth characteristic. The bac-

1983a, 1983b; Andrews et al. 1985; Corbeil et terium grows in a 5-10% CO2 atmosphere (Ken- al. 1985; Ames 1987; Jackson et al. 1987; Go- nedy et al. 1960; Claus y Rikihisa 1986; Inzana golewski et al. 1987a, 1987b, 1988; Potgieter and Corbeil 1987) and growth is enhanced by et al. 1988; Haritani et al. 1990; Kwiecien and the addition of pyridoxine, flavin mononucleo- Little 1990; Butt et al. 1993; Tegtmeier et al. tide, riboflavin and thiamine monophosphate 2000; Descarga et al. 2002). The occurrence to the medium (Inzana and Corbeil 1987). As of asymptomatic carriers, mainly in the genital quality control standards for H. somni, it is tract, is relevant for the epidemiology, diagnosis recommended cation-adjusted Mueller-Hinton and control of the disease complex (Corbeil et broth and chocolate Mueller-Hinton agar for al. 1985; Rosendal y Boyd 1986; Groom et al. microdilution and disk diffusion testing, res- 1988; Greer et al. 1989; Kwiecien and Little pectively (McDertmont et al. 2001). H. somni 1990; Nielsen 1990; Corbeil 1990; Sylte et al. ferments glucose, reduces nitrate, and it is oxi- 2001). Although the existence of pathogenic dase-positive and catalase-negative (Waldhalm and non-pathogenic strains is clearly defined, et al. 1974). Bacteria of the Haemophilus group the factors that determine these different phe- (H. somni was previously classified within this notypes are still unknown. In this work, the group) require either hemin (X factor) or nico- clinical syndromes associated with H. somni, tinamide adenine dinucleotide (NAD, V factor) AN. VET. (MURCIA) 26: 5-21 (2010). PATHOGENICITY OF HISTOPHILUS SOMNI. PÉREZ, D. S., ET AL. 7 for optimal growth (Rosendal and Boyd 1960; Adherence. H. somni colonizes the sur- Angen et al. 2003). Satellitism is a phenomenon face of the mucous membranes and attaches that describes the ability of factor V-dependent to non-epithelial cells (Corbeil et al. 1985). Haemophilus colonies to utilize NAD secreted Both live and formalin-killed H. somni adhe- by other bacteria, such as Staphylococcus au- re to bovine aortic endothelial cells (Thomp- reus (Fink and St. Geme III 2006) and it is son and Little 1981; Kwiecien et al. 1994). used for the diagnosis of H. somni. However, Likely, non-pilus adhesins are involved in the the fact that H. somni isolates do not require adherence of the organism to the cell surface any of these factors for growth made uncertain (Sethi and Murphy 2001). A bacterial surface its taxonomic position (Humphrey et al. 1982; protein, p76, would play a role in adherence Claus and Rikihisa 1986; Rosendal and Boyd (Sanders et al. 2003). 1986). H. somni shares 60% and 44% of ge- Iron uptake. Competition of H. somni and netic homology with the host for nutrients seems to be key for in vivo and Actinobacillus lignieresii, respectively (Ro- multiplication of the pathogen (Corbeil 1990). sendal and Boyd 1986). Nevertheless, its close In the host, most of the extracellular iron is phenotypic relationship with Haemophilus agni bound to transferrin or lactoferrin and the bacte- (H. agni) and Histophilus ovis (H. ovis) (Canto rium utilizes these iron pools in order to sustain et al. 1983; Rosendal and Boyd 1986; Ounna- its growth (Ounnariwo et al. 1990; Sethi and riwo et al. 1990; Ward et al. 1995) suggests that Murphy 2001). Studies on experimentally-indu- these organisms should be considered in a sepa- ced H. somni pneumonia demonstrated that cal- rate taxon of the Haemophilus-Actinobacillus- ves with the lowest pre-exposure serum trans- Pasteurella (HAP) group. Protein profiles from ferrin levels developed the most severe pneu- H. agni and H. ovis are very similar to bovine monic lesions. Thus, serum transferrin concen- H. somni (Ounnariwo et al. 1990). In addition, tration at the time of exposure may influence members of the family have ge- the outcome of the infection (McNair 1998). nomic patterns completely different from those The acquisition of iron from transferrin depends of H. somni and H. ovis, whereas isolates of on transferrin-binding proteins, which are pre- H. ovis are indistinguishable from those of H. sent in the bacterial outer membrane (Sethi and somni (Appuhamy et al. 1995). Recently, it was Murphy 2001). The iron-regulated outer mem- determined that H. somni, H. agni and H. ovis brane proteins (OMPs) of H. somni seem to di- represent the same species and it was proposed ffer among strains. Particularly, genital isolates to allocate them to a novel genus within the showed a high variability in their iron-regulated family Pasteurellaceae, with the name Histo- protein profiles (Wedderkopp et al. 1993). H. philus somni (Angen et al. 2003). somni utilizes a receptor-mediated mechanism for iron acquisition and it is able to obtain iron VIRULENCE FACTORS for growth from transferrin of bovine origin, but not from other mammalian species (Ounnariwo H. somni can cause localized or septicemic et al. 1990). For example, H. somni binds bo- disease (Corbeil 1990). However, the determi- vine transferrin, but not ovine transferrin. This nants of virulence and the mechanisms involved was proposed as one of the causes of the host in the development of the different pathological specificity of H. somni. However, H. somni is conditions have not been clearly defined (Inza- also associated with respiratory disease in Ame- na and Todd 1992). The following are some of rican bison and domestic , which harbor the factors that would contribute to H. somni the microorganism in their reproductive tract infection: (Ward et al. 1995). 8 AN. VET. (MURCIA) 26: 5-21 (2010). PATHOGENICITY OF HISTOPHILUS SOMNI. PÉREZ, D. S., ET AL.

Antigenic variation of surface proteins. sist systemically by escaping recognition by the OMPs are important immunological structures host immune response (Corbeil 1990; Inzana et because they are accessible to the host defen- al. 1992). se mechanisms (Nielsen 1990; Tagawa et al. Immunoglobulin-binding proteins (Ig- 1993). The major OMP of H. somni strains are BPs). IgBPs are thought to enable H. somni diverse in molecular mass and antigenic reacti- to evade antibody defenses (Corbeil and Bon- vity (Tagawa et al. 2003) and this may play an Durant 2001). High molecular weight (HMW) important role in the ability of the organisms to IgBPs and p76 are present in virulent strains cause infection (Sethi and Murphy 2001). Two of H. somni, (serum-resistant or SR strains), H. somni OMPs with molecular mass of 46 and but not in the isolates from asymptomatic ca- 14 kDa, common to all isolates tested, were rriers (serum-sensitive or SS strains) (Corbeil identified (Thomson et al. 1988). Moreover, a et al. 1997a). Likely, HMW IgBPs are the main 37 kDa heat-modifiable OMP (Tagawa et al. component of the fibrillar network that - mor 1993) and a 78 kDa OMP (Kania et al. 1990), phologically characterizes IgBP-positive strains which are surface exposed and highly conserved and which is absent in IgBP-negative strains. between isolates from carrier animals and ani- IgBP-positive strains are able to bind IgG2b, but mals with clinical disease were also described not IgG2a (Corbeil et al. 1997a, 1997b). This di- (Kania et al. 1990). A lipoprotein, lppB, is also fference in Fc binding between immunoglobu- predominantly expressed in the outer membra- lin allotypes to H. somni IgBPs was suggested ne fraction of H. somni (Theisen et al. 1993). to be relevant to disease since pathogenic H. However, the involvement of these proteins in somni strains with IgBP fibrils are resistant to H. somni pathogenesis is unknown. Immuniza- complement-mediated killing (Bastida-Corcue- tion of calves with a 40 kDa fraction of OMP ra et al. 1999). generates a humoral response (Corbeil et al. Non-immune mechanism of immunog- 1987). Although this molecule can be an impor- lobulin binding. This mechanism enables H. tant , the mechanisms involved somni to bind both IgM and IgG and it may in protection are not determined (Corbeil 1990). represent a microbial specific adaptation for Heterogeneity and phase variation of li- evasion of the host effector functions (Gogo- pooligosaccharides. H. somni lipopolysaccha- lewski et al. 1988), by masking bacterial sur- rides (LPS) lack the long, repeated polysaccha- face structures that are target of antibodies ride side chains, typically described for enteric or complement and by reducing opsonization Gram-negative bacteria. Thus, lipooligosaccha- and susceptibility to and killing rides (LOS) is a more accurate designation for (Widders et al. 1989). these structures. H. somni is able to incorpora- Immunoglobulin Fc receptors. Immunog- te neuraminic acid into its LOS. This process, lobulin Fc receptors are identified both on the known as sialylation, may block the binding of surface of H. somni and in the fluid phase (Cor- antibodies to certain epitopes and enhances the beil 1990). It is known that both pathogenic resistance to the bactericidal activity of serum and vaginal carrier isolates display binding of (Corbeil 1990; Inzana et al. 2002). Most cli- immunoglobulin Fc. However, this activity was nical isolates are capable of LOS sialylation, not detected in preputial isolates (Widders et whereas preputial isolates are not (Inzana et al. al. 1989). 2002; Siddaramppa and Inzana 2004). H. som- Histamine and hemolysin production. H. ni LOS can also be altered by phase variation somni is able to synthesize and secrete histami- (Inzana et al. 1992), a mechanism that appears ne. Thus, an IgE response might be involved in to enable pathogenic strains of H. somni to per- the pathogenesis of some infections, especially AN. VET. (MURCIA) 26: 5-21 (2010). PATHOGENICITY OF HISTOPHILUS SOMNI. PÉREZ, D. S., ET AL. 9 in the pneumonic form (Ruby et al. 2002). A 31 unable to kill the bacterium (Czuprynzki and kDa protein that possesses hemolytic activity Hamilton 1985; Hubbard et al. 1986; Lederer et was identified (Won and Griffith 1993). Howe- al. 1987; Czuprynski and Sample 1990; Pfeifer ver, studies associating H. somni hemolysin and et al. 1992; Yang et al. 1998). The survival of H. virulence have not been conducted. somni within PMNs would protect the pathogen from host defenses, allowing the invasion of SEROGROUPING OF H. SOMNI STRAINS different tissues (Pfeifer et al. 1992). It would also explain the difficultness to isolate the orga- Information on serogroups of H. somni nism from infected tissues or during bacteremia would be a valuable tool to assist in transmis- (Pfeifer et al. 1992) and would contribute to the sion studies and in the development of vaccines establishment of chronic, multisystemic infec- (Canto and Biberstein 1982; Won and Griffith tions (Lederer et al. 1987). H. somni interferes 1993). However, the attempts for grouping the with the oxidative burst of bovine neutrophils serological variants of H. somni have been in- (Czuprynzki and Hamilton 1985). Hubbard et conclusive. Six different variants of H. somni al. (1986) also suggested that H. somni would have been described. Variants 1, 2 and 3 have inhibit either the process of degranulation of been isolated from cattle (Bretschneider and primary granules or the myeloperoxidase ac- Cipolla 1999). The major antigens detected by tivity of neutrophils. H. somni stimulates the serology are heat-stable and are probably loca- production of nitric oxide (NO) by the infec- ted outside the LOS fraction since purified LOS ted PMNs. However, NO production is not an are un-reactive (Won and Griffith 1993). Mo- effective bactericidal mechanism against the reover, antigens containing H. somni LOS are pathogen (Gomis et al. 1997). Furthermore, not useful for serotyping due to their antigenic Yang et al. (1998) demonstrated that only direct phase variation (Howard et al. 2000). Tagawa et contact of intact, non-viable bacterium with bo- al. (2000) grouped H. somni variants according vine neutrophils is sufficient to induce cellular to their molecular mass and monoclonal anti- apoptosis. body reactivity of the major OMPs. They were able to group the strains isolated from different PATHOGENESIS OF THE SEPTICEMIC pathological conditions. However, they found DISEASE that isolates from asymptomatic carriers were distributed among all groups. These results su- Clinical disease associated with H. somni ggest that it will be necessary to identify the septicemia is classically divided into peracute, major sero-reactive antigens of H. somni and to acute, subacute and chronic. Only the peracu- develop proper serological tests for an accurate te and acute forms of the disease involve the classification of the different variants. nervous system (Ames 1987). Invasion of the bloodstream is the first step in the acute infec- INTERACTION OF H. SOMNI WITH tions induced by H. somni. It is not known whe- PHAGOCYTIC CELLS ther the bacteria harbored in the respiratory or genital tract are invasive. Although respiratory Lesions observed in natural infections by disease preceding development of TEME has H. somni are characterized by the presence of been described (Rosendal and Boyd 1986), it a large number of polymorphonuclear (PMN) was shown that after intra-tracheal inoculation, cells (Czuprynzki and Hamilton 1985; Hubbard H. somni is localized in the alveoli and bron- et al. 1986). Bovine neutrophils phagocytize H. chiolar lumen without detection of bacteremia somni (Andrews et al. 1985). However, they are (Groom et al. 1988). Thus, invasion and spread 10 AN. VET. (MURCIA) 26: 5-21 (2010). PATHOGENICITY OF HISTOPHILUS SOMNI. PÉREZ, D. S., ET AL. from the lungs seem uncommon. Thrombi for- encephalitic strain of H. somni in a wide range mation in the brain and kidney is observed af- of laboratory animal species only caused some ter bacteremia (Stephens et al. 1981; Rosendal non-characteristic lesions in hamsters (Dewey and Boyd 1986). Apoptosis of endothelial cells and Little 1984b). The intra-cisternal calf assay caused by the bacterium might be responsi- is regarded as the only reliable method to diffe- ble for the induction of thrombosis (Sylte et rentiate pathogenic from non-pathogenic strains al. 2001). H. somni LOS induce cell death by of H. somni. However, this is a costly assay and promoting the generation of intracellular reac- it is usually subject to human concerns (Kwie- tive oxygen species and NO (Sylte et al. 2001, cien and Little 1992). Endo-bronchial and en- 2004). Apoptosis would also contribute to H. do-tracheal inoculation of H. somni in calves somni pathogenesis through the impairment of consistently resulted in pneumonic lesions that immune surveillance and promotion of bacte- resemble the naturally occurring disease (Jack- rial survival (Sylte et al. 2006). LOS-induced son et al. 1987; Potgieter et al. 1988). However, apoptosis and adherence of the organism to the the appearance of an unusual number of abs- vascular endothelium are enhanced by TNF-α cesses after endo-tracheal inoculation, suggests (Sylte et al. 2006). Likely, this cytokine, pro- that a high number of bacteria is introduced duced during in vivo H. somni bacteremia, into focal sites when this methodology is used causes pro-coagulant activation and vascular (Jackson et al. 1987). These data suggest that damage that facilitates the development of le- the elaboration of in vitro tests would be useful sions (Kwiecien et al. 1994). Thompson and for studies of pathogenicity of H. somni strains Little (1981) suggested a probable sequence of and for the screening of carrier animals, espe- events involved in the vascular pathology: a) cially for exported live cattle and semen sam- adhesion of H. somni to vascular endothelium; ples (Kwiecien and Little 1992). b) contraction and desquamation of cells with exposure of sub-endothelial collagen and; c) EPIDEMIOLOGY thrombosis and vasculitis with the consequent ischemic of the adjacent parenchyma. H. somni is a commensal of the mucosal sur- The high antibody titers observed after intrave- face of the respiratory and genital tracts and the nous inoculation of H. somni might also lead agent usually spreads by direct contact (Rosen- to the formation of antigen/antibody complexes dal and Boyd 1986; Kwiecien and Little 1992). in the bloodstream, generating a type III hyper- Broncho-alveolar lavage fluids might contain a sensitivity reaction that causes vasculitis (Ste- high number of bacteria, even when nasal cultu- phens et al. 1981). However, vasculitis was also res are negative. This finding implies that once observed in H. somni antibody-negative calves, established, H. somni survives more readily in suggesting that bacteria/antibody complexes are the broncho-alveolar area than in the nasal mu- unlikely to contribute to the pathology. cosa and, as a consequence, coughing is a likely route for the transmission of the infection in EXPERIMENTAL MODELS animals that are negative to nasal cultures (Go- golewski et al. 1989). Whole blood and nasal Appropriate laboratory animal models for mucus are also a potential source of infection the study of infections by H. somni are not avai- since the bacterium is viable in these exudates lable. Mice and hamsters are susceptible to H. up to 70 days at 23.5 ºC. In a lesser extent, somni-induced after intra-peritoneal vaginal and nasal mucus can also be potentially inoculation (Inzana and Todd 1992). Intra- infective, with bacterial survival detected for 5 venous and intra-peritoneal inoculation of an days (Dewey and Little 1984a). Carrier animals AN. VET. (MURCIA) 26: 5-21 (2010). PATHOGENICITY OF HISTOPHILUS SOMNI. PÉREZ, D. S., ET AL. 11 must also be considered as another potential during natural infection and after intra-venous source of transmission of H. somni (Rosendal and intra-bronchial administration of H. somni. and Boyd 1986). Therefore, it was proposed that IgG2 antibodies Carrier state. H. somni is an organism for might have a role in limiting the hematogenous which both pathogenic and non-pathogenic va- dissemination of the organism. Antibodies in riants exist since cattle carrying the bacterium convalescent phase sera are directed to one or in absence of clinical disease is commonly de- more antigenically variable determinants of the tected. H. somni can be isolated from semen major OMP (Gogolewski et al. 1987b; Tagawa and preputial or vaginal mucosa from asympto- et al. 2000) and this protective antibody activity matic cattle, whereas pneumonic and encephali- may be strain specific (Tagawa et al. 1993). tic isolates always cause disease (Corbeil 1990; In vivo studies demonstrated that convalescent Groom et al. 1988). These findings demonstrate serum from pneumonic cattle protects against that H. somni is a commensal adapted to the H. somni-induced acute pneumonia and protec- genital mucosa, which rarely produces a local tion was correlated with both high IgG1 and inflammatory response (Kwiecien et al. 1994). IgG2 antibody titers (Gogolewski et al. 1987b). Corbeil et al. (1985) suggested that the presen- High levels of agglutinins have been detected ce of specific bacteria in the normal flora from in cattle that died after experimentally induced one animal to another may account for some TEME. Agglutinins antibodies are described as of the differences in strain virulence. Changes bactericidal antibodies that act by a comple- in the normal flora might lead to the develop- ment-independent mechanism (Simonson and ment of disease in carrier animals. For example, Maheswaran 1982). Bacillus spp., which is usually present in the regular mucosal flora, can affect the growth of CLINICAL SYNDROMES H. somni and Pasteurella spp. H. somni is ra- rely isolated from the normal upper respiratory Thromboembolic meningoencephalitis tract, although it is able to adhere to the nasal (TEME) epithelium (Rosendal and Boyd 1986). Therefo- re, enhancer species present among the genital, TEME is the most important condition cau- but not in the nasal flora, are a likely cause for sed by H. somni (Rosendal and Boyd 1986; the higher number of genital carriers (Corbeil et Descarga et al. 2002). It was first described al. 1985). Asymptomatic carrier isolates do not in 1956, in Colorado (Griner et al. 1956). The cause septicemia and vasculitis. Thus, it seems causative agent was identified in 1960, as a that in vivo, these isolates are unable to reach Haemophilus-like organism (Kennedy et al. the vascular endothelium (Starost 2001). 1960). TEME occurs typically in feedlot cal- ves, especially a few weeks after their arrival IMMUNE RESPONSE TO H. SOMNI (Griner et al. 1956; Rosendal and Boyd 1986; Descarga et al. 2002). However, the syndrome The common occurrence of H. somni in has also been described in grazing cattle (Gri- the reproductive tract states the possibility that ner et al. 1956; Smith and Biberstein 1977). many clinically normal cattle possess antibo- The morbidity is usually low but high morta- dies against the organism (Nielsen 1990). Ac- lity is observed (Rosendal and Boyd 1986). cording to these findings, Stephens et al. (1981) Death can occur within 12 hours of the onset found that 91.2% of asymptomatic cattle had of clinical signs (Kennedy et al. 1960; Smith titers to H. somni. Widders et al. (1986) de- and Biberstein 1977; Descarga et al. 2002) or monstrated a high and persistent IgG2 response the clinical manifestations can last as long as 12 AN. VET. (MURCIA) 26: 5-21 (2010). PATHOGENICITY OF HISTOPHILUS SOMNI. PÉREZ, D. S., ET AL. three weeks (Griner et al. 1956). Clinical sig- et al. 2000). Septicemic invasion rarely occurs ns involve blindness, recumbency, depression, after a pneumonic H. somni infection (Rosendal fever, anorexia and periods of excitement and and Boyd 1986; Potgieter et al. 1988; Groom irritability (Griner et al. 1956; Kennedy et al. et al. 1988). Pneumonic disease can be easily 1960; Smith and Biberstein 1977; Stephens et reproduced with pneumonic H. somni isolates. al. 1981; Descarga et al. 2002). Although less In contrast, preputial and encephalitic strains frequently, strabismus, nistagmus and opistho- fail to induce the disease after intra-tracheal tonus can occur (Kennedy et al. 1960). Gross inoculation. In addition, these strains seem lesions are mainly present in the brain and are to be more efficiently cleared from the lung usually bilateral and asymmetrical (Griner et al. parenchyma (Groom et al. 1988). H. somni is 1956; Stephens et al. 1981). Commonly, brain commonly associated with the undifferentiated lesions consist of multifocal, dark-red areas of bovine respiratory disease (UBRD) complex. necrosis and fibrinopurulent meningitis (Ken- Nevertheless, it is not considered as the main nedy et al. 1960; Smith and Biberstein 1977; agent associated with this condition (O´Connor Stephens et al. 1981; Momotani et al. 1985). et al. 2001). In some cases, H. somni is the sole Pericarditis, , bronchopneumonia, agent recovered from pneumonic lesions (Teg- hemorrhagic lymphadenitis, renal infarcts and tmeier et al. 2000). However, concurrent infec- polyarthritis are also present in cases of TEME tions with P. multocida, M. haemolytica and C. (Griner et al. 1956; Kennedy et al. 1960; Smith pyogenes can also be detected (Haritani et al. and Biberstein 1977). Microscopic lesions are 1990). Lesions observed in natural cases of H. characterized by vasculitis with neutrophilic somni respiratory disease consist of fibrinous infiltration, degeneration of macrophages, and suppurative pneumonia and bronchopneumo- numerous lymphocytic perivascular cuffs and nia (Andrews et al. 1985; Jackson et al. 1987). areas of focal necrosis (Griner et al. 1956; Des- Commonly, necrotizing bronchiolitis, vasculitis carga et al. 2002; Kennedy et al. 1960; Momo- and interstitial inflammation are observed (An- tani et al. 1985; Smith and Biberstein 1977; drews et al. 1985; Gogolewski et al. 1987a). Stephens et al. 1981). Randomly distributed By immunohistological staining, H. somni can thrombi, composed of fibrin, leukocytes and be detected in large aggregates within alveoli, bacterial colonies are present in all cases (Gri- perivascular connective tissue, airway exudates, ner et al. 1956, Kennedy et al. 1960; Stephens and within the cytoplasm of alveolar macropha- et al. 1981; Momotani et al. 1985). Microabs- ges (Gogolewski et al. 1987a; Tegtmeier et al. cessation and myelitis have also been reported 1999). Degeneration of alveolar macrophages (Griner et al. 1956; Smith and Biberstein 1977). is described as characteristic of H. somni pneu- Polioencephalomalacia, lead poisoning and lis- monia (Gogolewski et al. 1989). Contrary to teriosis must be considered in the differential the rapid spread of M. haemolytica in the res- diagnosis of TEME (Ames 1987; Smith and piratory tract, H. somni has little tendency to Biberstein 1977). disseminate within the lungs, a fact that would contribute to the chronic progression of the di- Pneumonia sease (Potgieter et al. 1988).

Diseases of the respiratory tract are of im- Reproductive tract disease portant economical concern both in beef and dairy cattle. Stress, concomitant infections or Both pathogenic and non-pathogenic strains immunosuppression are required for the esta- of H. somni colonize the bovine reproductive blishment of bacterial pneumonia (Tegtmeier tract (Bastida-Corcuera et al. 1999; Corbeil AN. VET. (MURCIA) 26: 5-21 (2010). PATHOGENICITY OF HISTOPHILUS SOMNI. PÉREZ, D. S., ET AL. 13

1990; Kwiecien and Little 1992). Although the bronchioles. Experimental abortion after intra- differences in virulence between isolates from venous inoculation of H. somni demonstrated neurological disease and from the reproductive that the bacterium is able to reach the pregnant tract are evident, there are no biochemical fea- uterus and placenta by hematogenous dissemi- tures that allow distinction between these stra- nation (Widders et al. 1986). H. somni-induced ins (Miller et al. 1983a). abortion was also reproduced by intra-amniotic Female reproductive tract. Reproducti- inoculation and the lesions observed in placenta ve failure caused by H. somni can occur ei- resembled the vascular changes associated with ther via systemic hematogenous dissemination bacterial septicemia (Miller et al. 1983b). (abortion) or by ascending route from vagina Male reproductive tract. H. somni is com- (Corbeil and BonDurant 2001). H. somni cau- monly recovered from the male bovine repro- ses vulvovaginitis, endometritis, cervicitis and ductive tract in the absence of pathological le- abortion (Firehammer 1956; Chladek 1975; sions. The preputial prevalence of the pathogen Widders et al. 1986; Hoblet et al. 1989). Howe- is very high (71%), particularly in young bulls. ver, under natural conditions, the pathological The organism is also harbored in accessory significance of the isolation of H. somni from glands (19%) and in the ampulla of the ductus vaginal discharges is difficult to interpret. H. deferens (10%) (Humphrey et al. 1982). Some somni is isolated at higher rates from inflamed strains can cause purulent posthitis and distal uterus and cervixes than from normal organs urethritis and spermatic abnormalities, with (22% vs. 8% and 39% vs. 10%, respectively). slow and non-progressive motility (Bretschnei- The fact that the pathogen is also isolated from der and Cipolla 1999). normal reproductive tracts implies that these strains cannot always be associated with disea- Mastitis se. H. somni persists in the cervico-vaginal area from periods ranging from 8 to 87 days post- The mature beef cow udder is not an im- inoculation, even in the presence of humoral portant site for the persistence of H. somni. response (Hoblet et al. 1989). The main site of However, experimental inoculation of the ma- bacterial persistence is unknown; however, the mmary gland with an encephalitic strain of H. major vestibular gland is considered a signifi- somni produced acute gangrenous mastitis with cant reservoir of H. somni (Miller et al. 1983). systemic dissemination of the organism. Chro- The detrimental effect of H. somni on embryo nic, subclinical mastitis can also be observed development was proposed as a possible cause (Hazzlet et al. 1989). Isolation of the organism of infertility in subclinically infected cows (Van from milk samples from cows with clinical Donkersgoed et al. 1990). mastitis has also been demonstrated (Greer et Abortion. Firehammer (1959) reported for al. 1989). the first time the isolation of a member of the genus Haemophilus from a bovine fetus aborted OTHER SYNDROMES ASSOCIATED at 7 months of pregnancy and from the vagi- WITH H. SOMNI INFECTION nal secretions of the aborted cow a month after abortion. Chladek (1975) reported the isolation H. somni has been isolated in pure culture of H. somni from the placenta and lung of a fetus from an urachal abscess in a 2 months old calf. aborted at 8.5 month of gestation. Gross lesions Lesions in other organs were not observed. An were not observed and microscopic lesions con- infected birth canal or contacts of the calf um- sisted of focal necrosis of placental cotyledons bilicus with a contaminated environment were and leukocyte infiltrates in fetal alveoli and possible causes of infection (Starost 2001). 14 AN. VET. (MURCIA) 26: 5-21 (2010). PATHOGENICITY OF HISTOPHILUS SOMNI. PÉREZ, D. S., ET AL.

Although the etiology of the weak calf syn- the measurement of antibodies against H. somni drome remains unknown, in some instances H. are not sufficiently sensitive or specific. The- somni has been associated with this manifesta- refore, it is suggested to use multiple serolo- tion. H. somni was isolated from 24% of cows gic tests in research situations (Stephens et al. that delivered weak calves and only from 6.5% 1981; Groom and Little 1988). of cows with normal calves in the same herd (Stauber 1986). The condition has also been VACCINES experimentally reproduced by intra-uterine ino- culation of H. somni at breeding (Waldhalm et The development of an effective vacci- al. 1974). ne against all clinical forms of the H. somni H. somni has been isolated from clinical ca- complex requires a proper characterization ses of severe conjunctivitis. However, there is of the differences between strains (Primal et no evidence whether the organism was present al. 1990). The fact that OMPs and LOS are as a commensal in the conjunctival sac or whe- antigenically variable imposes an obstacle in ther it plays a role in the disease (Lamont and the elaboration of immunogens (Howard et Hunt 1982). al. 2000; Corbeil and BonDurant 2001). Mo- Schuh and Harland (1991) described for reover, the lack of sensitive and specific sero- the first time myocarditis due to H. somni in logical tests contributes to the difficultness in Canada. Haines et al. (2004) demonstrated that the evaluation of vaccine efficacy (Groom and H. somni is the main agent associated with Little 1988). Results from studies with com- myocarditis in feedlot calves. In contrast, Ga- mercial bacterins are variable. Van Donkers- gea et al. (2006) indicated that from 8 cases god et al. (1994) did not observe a significant of myocarditis in calves, H. somni was isola- change in antibody titers after with ted from the lung of one case with concurrent a combined M. haemolytica-H. somni bacterin, bronchopneumonia and TEME, but never from whereas Groom and Little (1988) demonstra- the heart. ted that two with a whole cell H. somni bacterin were able to reduce the clinical CONSIDERATIONS ON THE DIAGNOSIS and pathological effects of H. somni-induced pneumonia after intra-tracheal challenge. An H. somni is difficult to grow in culture, experimental vaccine composed of an anio- especially from samples of infected tissues nic antigen present in the outer membrane or from environmental samples (Angen et al. complex of H. somni, induced a high level of 1998; Pfiefer et al. 1992). The identification of serum antibodies. However, control animals H. somni in genital secretions is improved when that developed TEME after challenge also had a guarded swabbing technique, which reduces a detectable increase in antibody response. the contamination level, in combination with Therefore, it was concluded that protection KD-columbia agar as a selective medium, is against TEME might be independent of the used (Kwiecien and Little 1992). A PCR test humoral response (Stephens et al. 1984). Butt that uses primers specific for the 16S rRNA of et al. (1991) demonstrated that intra-muscular H. somni was shown to be useful for the iden- immunization with OMP-270 from H. somni tification of the bacterium in mixed populations in cows, at oestrus, contributed to the pre-

(Angen et al. 1998). Tegtmeier et al. (2000) sence of IgG1 and IgG2 in uterine secretions. also demonstrated that the PCR technique was Although intra-uterine infusion of OMP-270 the most sensitive method for the identification at oestrus did not elicit a highly significant of H. somni-induced calf pneumonia. Tests for PMN effusion, these findings are important for AN. VET. (MURCIA) 26: 5-21 (2010). PATHOGENICITY OF HISTOPHILUS SOMNI. PÉREZ, D. S., ET AL. 15 the development of protection in the bovine REFERENCES reproductive tract since bovine PMNs express

Fc receptor for IgG2, which would assist in the AMES T.R. 1987. Neurologic disease caused clearance of infection (Butt et al. 1993). by Haemophilus somnus. Vet Clin North Am. Food Anim Pract 3:61-73. TREATMENT ANDREWS J.J., ANDERSON T.D., SLIFE L.N., STEVENSON G.W. 1985. Microsco- Prophylactic mass medication is an alterna- pic lesions associated with the isolation of tive management practice to reduce infection H. somnus from pneumonic bovine lungs. disease in feedlot calves. Van Donkersgoed et Vet. Pathol 22:131-136. al. (1994) showed that long-acting oxytetracy- ANGEN O., AHRENS P., TEGTMEIER C. cline did not reduce the risk of haemophilosis 1998. Development of a PCR test for identi- mortality. According to Welsh et al. (2004) has fication of Haemophilus somnus in pure and a variable susceptibility to spectinomycin and mixed cultures. Vet. Microbiol 63:39-48. sulfachloropyridizine. However, it is highly ANGEN O., AHRENS P., KUHNERT P., susceptible to other antibiotics of regular use, CHRISTENSEN H., MUTTERS R. 2003. such as ampicillin and (Harris and Proposal of Histophilus somni gen. Nov., Janzen 1989; Welsh et al. 2004). sp. Nov. for the three species incertae sedis Haemophilus somnus, Haemophilus agni CONCLUDING REMARKS AND FUTURE and Histophilus ovis. Int J Syst Evol Micro- DIRECTIONS biol 53:1449-1456. APPUHAMY S., PARTON R., COOTE J.G., More than 50 years ago, Histophilus somni GIBBS H.A. 1997. Genomic fingerprinting was described as an organism associated with of Haemophilus somnus by a combination the occurrence of TEME in cattle. Since this of PCR methods. J Clin Microbiol 35:288- first report, the pathogen has been associated 291. with a variety of clinical syndromes. Its rele- BASTIDA-CORCUERA F.D., NIELSEN K.H., vance in veterinary medicine is mainly related CORBEIL L.B. 1999. Binding of bovine Ig- to the economical losses it causes in the feedlot G2a and IgG2b allotypes to protein A, pro- industry. However, despite its recognized signi- tein G, and Haemophilus somnus IgBPs. Vet ficance as a pathogen of cattle, little is known Immunol Immunopathol 71:143-149. about the biological properties of the bacterium. BRETSCHNEIDER G., CIPOLLA A. 1999. The development of an effective vaccine against Haemophilus somnus: una revisión sobre su the disease complex will require a thorough implicancia en el tracto reproductivo bovi- understanding of the determinants of virulence no. Therios 28: 251 - 260. responsible for the different clinical conditions. BUTT B.M., SENGER P.L., WIDDERS P.R. Identification of the relevant antigens of H. 1991. Neutrophil migration into the bovine somni that are recognized by the host immune uterine lumen following intrauterine inocu- system is also essential. New methodologies to lation with killed H. somnus. J Reprod Fert test differences in virulence between strains and 93:334-345. to evaluate the contribution of the non-pathoge- BUTT B.M., BESSER T.E., SENGER P.L., nic strains to the immunological response and WIDDERS P.R. 1993. Specific antibody to epidemiology will also provide new tools for H. somnus in the bovine uterus following the control of the disease. intramuscular immunization. Infect Immun 61:2558-2562. 16 AN. VET. (MURCIA) 26: 5-21 (2010). PATHOGENICITY OF HISTOPHILUS SOMNI. PÉREZ, D. S., ET AL.

CANTO L., BIBERSTEIN E.L., SCHULTE Haemophilus somnus in cattle. Am J Vet T.A., BEHYMER D. 1983. Cross-reactivity Res 38:1749-1751. of Haemophilus somnus antibody in agglu- Czuprynski C.J., Hamilton H.L. 1985. Bovi- tination and complement fixation tests and ne neutrophils ingest but do not kill Hae- in the enzyme-linked immunosorbent assay. mophilus somnus in vitro. Infect Immun J Clin Microbiol 17:500-506. 50:431-436. CANTO G.J., BIBERSTEIN E.L. 1982. Sero- CZUPRYNSKI C.J., SAMPLE A.K. 1990. In- logical diversity in Haemophilus somnus. J teractions of Haemophilus-Actinobacillus- Clin Microbiol 15:1009-1015. Pasteurella bacteria with phagocytic cells. CHLADEK D.W. 1975. Bovine abortion as- Can J Vet Res 54:S36-S40. sociated with H. somnus. Am J Vet Res DESCARGA C.O., PISCITELLI H.G., ZIE- 36:1034. LINSKI G.C., CIPOLLA A.L. 2002. CLAUS G.W., RIKIHISA Y. 1986. Haemo- Thromboembolic meningoencephalitis due philus. In: GR Carter editor, Essentials of to Haemophilus somnus in feedlot cattle in Veterinary Bacteriology and Mycology, 3º Argentina. Vet Rec 150:817. ed. Lea & Febiger, Philadelphia, PA, p. 172- DEWEY K.J., LITTLE P.B. 1984. Environmen- 175. tal survival of Haemophilus somnus and in- CORBEIL L.B., WOODWARD W., WARD fluence of secretions and excretions. Can J A.C., MICKELSEN W.D., PAISLEY L. Comp Med 48:23-26. 1985. Bacterial interactions in bovine res- DEWEY K.J., LITTLE P.B. 1984. The patho- piratory and reproductive infections. J Clin genicity of Haemophilus somnus in various Microbiol CORBEIL L.B., ARTHUR J.E., laboratory animal species. Can J Comp Med WIDDERS P.R., SMITH J.W., BARBET 48:27-29. A.F. 1987. Antigenic specificity of conva- FINK D.L., ST GEME III J. 2006. The genus lescent serum from cattle with Haemophilus Haemophilus. Prokaryotes. 6: 1034-1061. somnus-induced experimental abortion. In- FIREHAMMER B.D. 1959. Bovine abortion fect Immun 55:1381-1386. due to Haemophilus species. J Am Vet Med CORBEIL L.B. 1990. Molecular aspects of Assoc 135:421-422. some virulence factors of Haemophilus GAGEA M.I., BATEMAN K.G., VAN DREU- somnus. Can J Vet Res 54:S57-S62. MEL T., MCEWEN B.J., CARMAN S., CORBEIL L.B., BASTIDA-CORCUERA F.D., ARCHAMBAULT M., SHANAHAN R.A., BEVERIDGE T.J. 1997. Haemophilus som- CASWELL J.L. 2006. Diseases and patho- nus immunoglobulin binding proteins and gens associated with mortality in Ontario surface fibrils. Infect Immun 65:4250-4257. beef feedlots. J Vet Diagn Invest 18:18-28. CORBEIL L.B., GOGOLEWSKI R.P., KAC- GOGOLEWSKI R.P., LEATHERS C.W., LI- SKOVICS I., NIELSEN K.H., CORBEIL GGIT H.D., CORBEIL L.B. 1987. Experi- R.R., MORRIL J.L., GREENWOOD R., mental Haemophilus somnus pneumonia in

BUTLER J.E. 1997. Bovine IgG2a antibo- calves and immunoperoxidase localization dies to Haemophilus somnus and allotype of bacteria. Vet Pathol 24:250-256. expression. Can J Vet Res 61:207-213. GOGOLEWSKI R.P., KANIA S.A., INZANA CORBEIL L.B., BONDURANT R.H. 2001. T.J., WIDDERS P.R., LIGGIT H.D., COR- Immunity to bovine reproductive infections. BEIL L.B. 1987. Protective ability and spe- Immunology 17:567-583. cificity of convalescent serum from calves CRANDELL R.A., SMITH A.R., KISSIL M. with Haemophilus somnus pneumonia. In- 1977. Colonization and transmission of fect Immun 55:1403-1341. AN. VET. (MURCIA) 26: 5-21 (2010). PATHOGENICITY OF HISTOPHILUS SOMNI. PÉREZ, D. S., ET AL. 17

GOGOLEWSKI R.P., KANIA S.A., LIGGITT HARRIS F.W., JANZEN E.D. 1989. The Hae- H.D., CORBEIL L.B. 1988. Protective abi- mophilus somnus disease complex (Hemo- lity of antibodies against 78- and 40-kilo- philosis): a review. Can J Vet Res 30:816- dalton outer membrane antigens of Haemo- 822. philus somnus. Infect Immun 56:2307-2316. HAZLETT M.J., LITTLE P.B., BARNUM GOGOLEWSKI R.P., SCHAEFER D.C., WAS- D.A., MAXIE M.G., LESLIE K.E., MI- SON S.K., CORBEIL R.R., CORBEIL L.B. LLER R.B. 1985. Haemophilus somnus: 1989. Pulmonary persistence of Haemo- investigations of its potential role in bovine philus somnus in the presence of specific mastitis. Am J Vet Res 46: 2229-2234. antibody. J Clin Microbiol 27:1767-1774. HOBLET K.H., HAIBEL G.K., KOWALSKI GOMIS S.M., GODSON D.L., WOBESER J.J., ROJKO J.L. 1989. Culture-positive per- G.A., POTTER A.A. 1997. Effect of Hae- sistence and serum agglutinating antibody mophilus somnus on nitric oxide production response after intrauterine inoculation of and chemiluminiscence response of bovine Haemophilus somnus in virgin heifers. Am blood monocytes and alveolar macrophages. J Vet Res 50:1009-1014. Microb Pathog 23:327-333 HOWARD M.D., COX A.D., WEISER J.N., GREER D., MCCONNEL W., BALL H. 1989. SCHURIG G.G., INZANA T.J. 2000. An- Isolation of Haemophilus somnus from bo- tigenic diversity of Haemophilus somnus vine milk. Vet Rec 125:381-382. lipooligosaccharide: phase-variable acces- GRINER L.A., JENSEN R., BROWN W.W. sibility of the phosphorylcholine epitope. J 1956. Infectious embolic encephalitis in Clin Microbiol 38:4342-4349. cattle. J Am Vet Med Assoc 129:347-421. HUBBARD R.D., KAEBERLE M.L., ROTH GROOM S.C., LITTLE P.B., ROSENDAL S. J.A., CHIANG Y.W. 1986. Haemophilus 1988. Virulence differences among three somnus-induced interference with bovine strains of Haemophilus somnus following neutrophils function. Vet Microbiol 12:77- intratracheal inoculation of calves. Can J Vet 85. Res 52:349-354. HUMPHREY J.D., LITTLE P.B., STEPHENS GROOM S.C., LITTLE P.B. 1988. Effects of L.R., BARNUM D.A., DOIG P.A., THOR- vaccination of calves against induced Hae- SEN J. 1982. Prevalence and distribution of mophilus somnus pneumonia. Am J Vet Res Haemophilus somnus in the male bovine re- 49:793-800. productive tract. Am J Vet Res 43:791-795. HAINES D.M., MOLINE K.M., SARGENT INZANA T.J., CORBEIL L.B. 1987. Develop- R.A., CAMPBELL J.R., MYERS D.J., DOIG ment of a defined medium for Haemophilus P.A. 2004. Immunohistochemical study of He- somnus isolated from cattle. Am J Vet Res. mophilus somnus, Mycoplasma bovis, Mann- 48:366-369. heimia hemolytica, and bovine viral diarrhea INZANA T.J., TODD J. 1992. Immune respon- virus in death losses due to myocarditis in se of cattle to Haemophilus somnus lipid feedlot cattle. Can Vet J 45:231-234. A-protein conjugate vaccine and efficacy HARITANI M., NAKASAWA M., HASHIMO- in a mouse abortion model. Am J Vet Res TO K., NARITA M., TAGAWA Y., NAKA- 53:175-179. GAWA M. 1990. Immunoperoxidase eva- INZANA T.J., GOGOLEWSKI R.P., COR- luation of the relationship between necrotic BEIL L.B. 1992. Phenotypic phase variation lesions and causative bacteria in lungs of in Haemophilus somnus lipooligosaccharide calves with naturally acquired pneumonia. during bovine pneumonia and after in vitro Am J Vet Res 51:1975-1979. passage. Infect Immun 60:2943-2951. 18 AN. VET. (MURCIA) 26: 5-21 (2010). PATHOGENICITY OF HISTOPHILUS SOMNI. PÉREZ, D. S., ET AL.

INZANA T.J., GLINDEMANN G., COX A.D., of broth microdilution and disk diffusion WAKARCHUK W., HOWARD M.D. 2002. susceptibility tests for Actinobacillus pleu- Incorporation of N-acetylneuraminic acid ropneumoniae and Haemophilus somnus: into Haemophilus somnus lipooligosaccha- quality control standards for ceftiofur, en- ride (LOS): enhancement of resistance to rofloxacin, florfenicol, gentamicin, penici- serum and reduction of LOS antibody bin- llin, tetracycline, tilmicosin, and trimetho- ding. Infect Immun 70: 4870-4879. prim-sulfamethoxazole. J Clin Microbiol JACKSON J.A., ANDREWS J.J., HARGIS, 39:4283-4287. J.W. 1987. Experimental Haemophilus som- McDONALD D.W., CHRISTIAN R.G., CHAL- nus pneumonia in calves. Vet Pathol 24:129- NERS G.A. 1973. Infectious thromboem- 134. bolic meningoencephalitis: literature review KANIA S.A., GOGOLEWSKI R.P., CORBEIL and occurrence in Alberta, 1969-1971. Can L.B. 1990. Characterization of a 78-kilodal- Vet J 14:57-61. ton outer membrane protein of Haemophilus MCNAIR J., ELLIOT C., BRYSON D.G., somnus. Infect Immun 58:237-244. MACKIE D.P. 1998. Bovine serum trans- KENNEDY F.C., BIBERSTEIN E.L., HOWAR- ferrin concentration during acute infec- TH J.A, FRAZIER L.M., DUNGWORTH tion with Haemophilus somnus. Br Vet J D.L. 1960. Infectious meningoencephalitis 155:251-255. in cattle, caused by a Haemophilus-like or- MILLER R.B., BARNUM D.A., MCENTEE ganism. Am J Vet Res 21:403-409. K.E. 1983. H. somnus in the reproductive KUCKLEBURG C.J., MCCLENAHAN D.J., tracts of slaughtered cows: location and fre- CZUPRYNSKI C.J. 2008. Platelet activa- quency of isolation and lesions. Vet Pathol tion by Histophilus somni and its lipooligo- 20:515-521. saccharide induces endothelial cell proinfla- MILLER R.B., LEIN D.H., MCENTEE K.E., mmatory responses and platelet internaliza- HALL C.E., SHIN S. 1983. Haemophilus tion. Shock 29:189-196. somnus infection of the reproductive tract KWIECIEN J.M., LITTLE P.B. 1992. Isolation of cattle: a review. J Am Vet Med Assoc of pathogenic strains of Haemophilus som- 182:1390-1392. nus from the female bovine respiratory tract. MILLER R.B., VAN CAMP S.D., BARNUM Can J Vet Res 56:127-134. D.A. 1983. The effects of intra-amniotic KWIECIEN J.M., LITTLE P.B, HAYES M.A. inoculation of Haemophilus somnus on the 1994. Adherence of Haemophilus somnus to bovine fetus and dam. Vet Pathol 20:574- tumor necrosis factor-alpha-stimulated bo- 583. vine endothelial cells in culture. Can J Vet MOMOTANI E., YABUKI Y., MHIO H., IS- Res 58:211-219. HIKAWA Y., YOSHINO T. 1985. Histo- LAMONT M.H., HUNT B.W. 1982. Haemo- pathological evaluation of disseminated philus somnus and conjunctivitis. Vet Rec intravascular coagulation in Haemophilus 111: 21. somnus infection in cattle. J Comp Pathol LEDERER J.A., BROWN J.F., CZUPRYNSKI 95:15-23. C.J. 1987. Haemophilus somnus, a facultati- NIELSEN R. 1990. New diagnostic techniques: ve intracellular pathogen of bovine mononu- a review of the HAP group of bacteria. Can clear phagocytes. Infect Immun 55:381-387. J Vet Res 54:S68-S72. MCDERMOT P.F., BARRY A.L., JONES R.N., O’CONNOR A., MARTIN S.W., NAGY E., STEIN G.E., THORNSBERRY C., WU MENZIES P., HARLAND R. 2001. The C.C., WALKER R.D. 2001. Standardization relationship between the occurrence of un- AN. VET. (MURCIA) 26: 5-21 (2010). PATHOGENICITY OF HISTOPHILUS SOMNI. PÉREZ, D. S., ET AL. 19

differentiated bovine respiratory disease and SIDDARAMPPA S., INZANA T.J. 2004. Hae- titer changes to Haemophilus somnus and mophilus somnus virulence factors and re- Manheimia haemolytica at 3 Ontario fee- sistance to host immunity. Anim Health Res dlots. Can J Vet Res 65:143-150. Rev 5:79-93. OUNNARIWO J.A., CHENG C., FORD J., SIMONSON R.R., MAHESWARAN S.K. SCHRYVERS, A.B. 1990. Response of Hae- 1982. Host humoral factors in natural re- mophilus somnus to iron limitation: expression sistance to Haemophilus somnus. Am J Vet and identification of a bovine-specific transfe- Res 43:10-14. rrin receptor. Microb Pathog 9:397-406. SMITH B.P., BIBERSTEIN E.L. 1977. Septi- PFEIFER C.G., CAMPOS M., BESKORWAY- cemia and meningoencephalitis in pastured NE T., BABIUK L.A., POTTER A.A. 1992. cattle caused by Haemophilus-like organism Effect of Haemophilus somnus on phago- (Haemophilus somnus). Cornell Vet 67:300- cytosis and hydrogen peroxide production 305. by bovine polymorphonuclear leukocytes. STAROST M.F. 2001. Haemophilus somnus Microb Pathog 13:191-202. isolated from an urachal abscess in a calf. POTGIETER L.N., HELMAN R.G., GREE- Vet Pathol 38:547-548. NE W., BREIDER M.A., THURBER E.T., STEPHENS L.R., LITTLE P.B., WILKIE B.N., PEETZ R.H. 1988. Experimental bovine BARNUM D.A. 1981. Humoral immunity respiratory tract disease with H. somnus. Vet in experimental thromboembolic menin- Pathol 25:124-130. goencephalitis in cattle caused by Haemo- PRIMAL S.V., SILVA S., LITTLE P.B. 1990. philus somnus. Am J Vet Res 42:468-473. The protective effect of vaccination against STEPHENS L.R. LITTLE P.B., WILKIE B.N., experimental pneumonia in cattle with Hae- BARNUM D.A. 1984. Isolation of Hae- mophilus somnus outer membrane antigens mophilus somnus antigens and their use as and interference by . vaccines for prevention of bovine thromboe- Can J Vet Res 54:326-330. mbolic meningoencephalitis. Am J Vet Res ROSENDAL S., BOYD D.A. 1986. Hemophi- 45:235-239. losis. In: CL Gyles and CO Thoen, editor. STAUBER E. 1976. Weak calf syndrome: a Pathogenesis of bacterial infections in ani- continuing enigma. J Am Vet Med Assoc mals, 1º ed., Iowa State University Press, 168:223-225. Ames, p. 132-136 SYLTE M.J., CORBEIL LB, INZANA TJ, RUBY K.W., GRIFFITH R.W., KAEBERLE CZUPRYNSKI CJ. 2001. Haemophilus M.L. 2002. Histamine production by Hae- somnus induces apoptosis in bovine endo- mophilus somnus. Comp Immunol Micro- thelial cells in vitro. Infect Immun 69: 1650- biol Inf Dis 25:13-20. 1660. SANDERS J.D., BASTIDA-CORCUERA F.D., SYLTE M.J., INZANA T.J., CZUPRYNSKI ARNOLD K.F., WUNDERLICH A.C., C.J. 2004. Reactive oxygen and nitrogen in- CORBEIL L.B. 2003. Genetic manipula- termediates contribute to Haemophilus som- tion of immunoglobulin binding proteins nus lipooligosaccharide-mediated apoptosis of Haemophilus somnus. Microb Pathog of bovine endothelial cells. Vet Immunol 34:131-139. Immunopathol 97:207-217. SETHI S., MURPHY T.F. 2001. Bacterial in- SYLTE M.J., KUCKLEBURG C.J., LEITE fection in chronic obstructive pulmonary di- F.P., INZANA T.J., CZUPRYNSKI C.J. sease in 2000: a state of the art review. Clin 2006.Tumor necrosis factor-alpha enhances Microbiol Rev 14:336-363. Haemophilus somnus lipooligosaccharide- 20 AN. VET. (MURCIA) 26: 5-21 (2010). PATHOGENICITY OF HISTOPHILUS SOMNI. PÉREZ, D. S., ET AL.

induced apoptosis of bovine endothelial VAN DONKERSGOED J., POTTER A.A., cells. Vet Immunol Immunopathol 110:303- MOLLISON B., HARLAND R.J. 1994. 309. The effect of a combined Pasteurella hae- TAGAWA Y., HARITANI M., ISIHIKAWA molytica and Haemophilus somnus vacci- H., YUASA N. 1993. Characterization of ne and a modified-live bovine respiratory a heat-modifiable outer membrane protein syncytial virus vaccine against enzootic of Haemophilus somnus. Infect Immun pneumonia in young beef calves. Can Vet 61:1750-1755. J 35:239-234. TAGAWA Y., BASTIDA-CORCUERA F., VAN DONKERSGOED J., JANZEN E., POT- CORBEIL L.B. 2000. Immunological cha- TER A., HARLAND R. 1994. The occurren- racterization of the major outer membrane ce of Haemophilus somnus in feedlot calves protein of Haemophilus somnus. Vet Micro- and its control by post-arrival prophylactic biol 71:245-254. mass medication. Can Vet J 35:573-580. TEGTMEIER C., BLOCH B., JENSEN N.E., WALDHALM D.G., HALL R.F., MEINERS- JENSEN H.E. 1999. Initial lung lesions in HAGEN W.A., CARD C.S., FRANK F.W. two calves experimentally infected with 1974. Haemophilus somnus infection in Haemophilus somnus. J Vet Med B 46:517- the cow as a possible contributing factor to 523. weak calf syndrome: isolation and animal TEGTMEIER C., ANGEN O., GRELL S.N., inoculation studies. Am J Vet Res 35:1401- RIBER U., FRIIS N.F. 2000. Aerosol cha- 1403. llenge of calves with Haemophilus somnus WARD A.C., JAWORSKI M.D., EDDOW J.M., and Mycoplasma dispar. Vet Microbiol CORBEIL L.B. 1995. A comparative study 72:229-239. of bovine and ovine Haemophilus somnus TEGTMEIER C., ANGEN O., AHRENS P. isolates. Can J Vet Res 59:173-178. 2000. Aerosol challenge of calves with Hae- WARD A.C., WEISER G.C., ANDERSON mophilus somnus and Mycoplasma dispar. B.C., CUMMINGS P.J., ARNOLD K.F., Vet Microbiol 76:385-394. CORBEIL L.B. 2006. Haemophilus somnus THEISEN M., RIOUX C.R., POTTER A.A. (Histophilus somni) in bighorn sheep. Can. 1993. Molecular cloning, nucleotide se- J. Vet. Res. 70:34-42. quence and characterization of lppB, enco- WEDDERKOPP A., PRIMAL S.V., SILVA S., ding an antigenic 40-kilodalton lipoprotein LITTLE P.B. 1993. Differences in protein of Haemophilus somnus. Infect Immun expression of Haemophilus somnus grown 61:1793-1798. under conditions of iron-restriction. Vet. Mi- THOMPSON K.G., LITTLE P.B. 1981. Effect crobiol. 35:91-100. of Haemophilus somnus on bovine endothe- WELSH R.D., DYE L.B, PAYTON M.E., lial cells in organ culture. Am J Vet Res CONFER, A.W. 2004. Isolation and anti- 42:748-754. microbial susceptibilities of bacterial patho- THOMSON M.S., STRINGFELLOW D.A., gens from bovine pneumonia: 1994-2002. J. LAUERMAN L.H. 1988. Adherence of Hae- Vet. Diagn. Invest 16: 426-431. mophilus somnus to bovine embryos after in WIDDERS P.R., PAISLEY L., GOGOLEWSKI vitro exposure. Am J Vet Res 49:63-66. G., EVERMANN J.F., SMITH J.W., COR- THOMSON M.S., LAUREMAN L.H., WILT BEIL L.B. 1986. Experimental abortion G.R. 1990. Monoclonal antibody in the and the systemic immune response to Hae- identification of Haemophilus somnus. J Vet mophilus somnus in cattle. Infect. Immun. Diagn Invest 2:116-119. 54:555-560. AN. VET. (MURCIA) 26: 5-21 (2010). PATHOGENICITY OF HISTOPHILUS SOMNI. PÉREZ, D. S., ET AL. 21

WIDDERS P.R., DORRANCE L.A., YAR- lodalton antigen of Haemophilus somnus. NALL M., CORBEIL L.B. 1989. Immuno- Infect. Immun. 61: 2813-2821. globulin-binding activity among pathogenic YANG Y.F., SYLTE M.J., CZUPRYNSKI, and carrier isolates of Haemophilus somnus. C.J. 1998. Apoptosis: a possible tactic of Infect. Immun. 57:639-642. Haemophilus somnus for evasion of killing WON J., GRIFFITH R.W. 1993. Cloning and by bovine neutrophils? Microb. Pathog. sequencing of the encoding a 31-ki- 24:351-359.